University of Georgia

• Science & Technology

Nasal COVID-19 Vaccine Secures Federal Funding for Groundbreaking Clinical Trial

CyanVac LLC is set to begin a federally funded Phase 2b trial this fall for its intranasal COVID-19 vaccine, CVXGA,…